Gene S has developed an innovative PGx platform technology called Rosa, named in honour of Rosalind Franklin, a British scientist who made crucial contributions to understanding the physical structure of DNA, known as the double helix. Rosa has been developed for medications firstly to treat mental health conditions in both adults and children (RosaMind). 

The Rosa PGx platform will then be applied to medications used in the management of pain, cardiac conditions, and anaesthesia with future application for anti-bugs, cancer and animal health.